FLORHAM PARK, N.J., June 16, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for ...

FLORHAM PARK, N.J., June 16, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for ...

Article citations More>> U.S. Food and Drug Administration (FDA) (2023) Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book). has been cited by the following article: TITLE: ...

FLORHAM PARK, N.J., June 16, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing ...

It's not the first time Teva has been judged to have broken European antitrust rules: in November 2020 the EU fined Teva and its neurology unit Cephalon €60.5 million for an elaborate "pay for ...

You may be able to get a 90-day supply of Doptelet. If approved by your insurance company, getting a 90-day supply of the drug could reduce your number of trips to the pharmacy and help lower the ...

The drug information contained herein is subject to change and is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects.

Researchers from the George Washington University have uncovered promising evidence in an animal study that shows setmelanotide, an FDA-approved medication for a rare genetic obesity disorder, may ...

By Upsher-Smith Laboratories, LLC Jun 16, 2025 Updated Jun 16, 2025 ...

Given FD&C colors have a longstanding history of approval by the U.S. Food & Drug Administration, Kraft Heinz has used the colors in a small number of products.

Approved Drug Products with Therapeutic Equivalence Evaluations (the “Orange Book”) to accurately reflect the full 10-year period of non-patent New Chemical Entity (NCE) exclusivity for ...

The Food and Drug Administration (FDA) has approved Yeztugo (aka. lenacapavir or LEN), a twice-a-year injection that stops HIV from replicating inside cells, thereby reducing the risk of ...